Prone Position and Renal Resistive Index (PRO-KIDNEY)

May 11, 2020 updated by: University Hospital, Grenoble

Effect of Prone Position on Renal Resistive Index Among Patients With Acute Respiratory Distress Syndrome. The Role of Intra-abdominal Pressure

Patients suffering from Acute Respiratory Distress Syndrome (ARDS) with a prone position (PP) indication will benefit from measurements of radiological and biological kidney injury markers, intra-abdominal pressure (IAP) and ventilatory mechanics in supine position (baseline IAP), after 2 hours in PP at the current IAP value, thirty minutes after patients' abdomen suspension in order to resume baseline IAP and after patients' are turned back to supine position.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ARDS patients according to Berlin criteria, intubated, mechanically ventilated since at least 24 hours,
  • with PaO₂/FiO₂ < 150 mmHg,
  • neuromuscular blockade
  • with an indication of PP done by the physician in charge
  • possibility to differ PP for one hour
  • patients should be hemodynamically stable since at least 4 hours

Exclusion Criteria:

  • Pregnant or breast-feeding women
  • legal protection, no social security affiliation
  • PP contra-indication
  • nasogastric tube contra-indication
  • extra corporeal membrane oxygenation
  • acute kidney injury at inclusion according to K-DIO criteria, chronic kidney disease defined as an estimated glomerualr filtration rate less than 30 ml/min/1.73m², kidney transplantation, renal artery stenosis, solitary kidney, albuminuria > 1.25 mg/ml
  • cardiac arrhythmia
  • obesity
  • advanced cirrhosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Prone position
Abdomen suspension in prone position

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in renal resistive index (RRI)
Time Frame: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
RRI measurement will be performed on a right kidney arcuate/interlobar artery, with a high frequency Doppler probe. Three to five consecutive measures will be obtained then RRI computed according to the formula: (peak systolic velocity - end diastolic velocity)/peak systolic velocity).
At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in renal medullary oxygen tension
Time Frame: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
urinary oxygen tension (uPO₂) will be measured via a fiber-optic luminescence optode inserted through the bladder catheter lumen
At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
change in cell-cycle arrest biomarkers
Time Frame: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
Tissue inhibitor of metalloproteinases 2 and Insulin-like growth factor-binding protein 7 concentrations product ([TIMP2] · [IGFBP7]) will be measured with a sandwich immunoassay technique
At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
ventilatory mechanics: transpulmonary pressure
Time Frame: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
transpulmonary pressure will be measured at the end of inspiration and expiration and continuously recorded on a datalogger
At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
ventilatory mechanics: driving pressure
Time Frame: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
driving pressure will be measured at the end of inspiration and expiration and continuously recorded on a datalogger
At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
ventilatory mechanics: elastance
Time Frame: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
elastance will be measured at the end of inspiration and expiration and continuously recorded on a datalogger
At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
haematosis
Time Frame: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
arterial oxygen tension (PaO2) and arterial dioxide carbon tension (PaC02)
At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver
Intra abdominal pressure
Time Frame: At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver and two hours after patients are back in supine position
Intra abdominal pressure will be measured thanks to a dedicated nasogastric tube with two balloons (gastric pressure)
At inclusion (in supine position), two hours after prone positioning, 30-minutes after the abdomen suspension maneuver and two hours after patients are back in supine position
Persisting effect of IAP increase in prone position when patients are back in supine position on renal resistive index
Time Frame: Two hours after patients are back in supine position
RRI measurement will be performed on a right kidney arcuate/interlobar artery, with a high frequency Doppler probe. Three to five consecutive measures will be obtained then RRI computed according to the formula: (peak systolic velocity - end diastolic velocity)/peak systolic velocity).
Two hours after patients are back in supine position
Persisting effect of IAP increase in prone position when patients are back in supine position on urinary PO2
Time Frame: Two hours after patients are back in supine position
urinary oxygen tension (uPO₂) will be measured via a fiber-optic luminescence optode inserted through the bladder catheter lumen
Two hours after patients are back in supine position
Persisting effect of IAP increase in prone position when patients are back in supine position on cell-cycle arrest biomarkers
Time Frame: Two hours after patients are back in supine position
Tissue inhibitor of metalloproteinases 2 and Insulin-like growth factor-binding protein 7 concentrations product ([TIMP2] · [IGFBP7]) will be measured with a sandwich immunoassay technique
Two hours after patients are back in supine position
Persisting effect of IAP increase in prone position when patients are back in supine position on ventilatory mechanics: transpulmonary pressure
Time Frame: Two hours after patients are back in supine position
transpulmonary pressure will be measured at the end of inspiration and expiration and continuously recorded on a datalogger
Two hours after patients are back in supine position
Persisting effect of IAP increase in prone position when patients are back in supine position on ventilatory mechanics: driving pressure
Time Frame: Two hours after patients are back in supine position
driving pressure will be measured at the end of inspiration and expiration and continuously recorded on a datalogger
Two hours after patients are back in supine position
Persisting effect of IAP increase in prone position when patients are back in supine position on ventilatory mechanics: elastance
Time Frame: Two hours after patients are back in supine position
elastance will be measured at the end of inspiration and expiration and continuously recorded on a datalogger
Two hours after patients are back in supine position
Persisting effect of IAP increase in prone position when patients are back in supine position on haematosis
Time Frame: Two hours after patients are back in supine position
arterial oxygen tension (PaO2) and arterial dioxide carbon tension (PaC02)
Two hours after patients are back in supine position
Acute kidney injury
Time Frame: within 48 hours following prone position
According to creatinine or diuresis criteria of Kidney Disease: Improving Global Outcomes (K-DIGO) classification
within 48 hours following prone position

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

June 1, 2020

Primary Completion (ANTICIPATED)

June 1, 2022

Study Completion (ANTICIPATED)

June 1, 2022

Study Registration Dates

First Submitted

February 18, 2020

First Submitted That Met QC Criteria

February 26, 2020

First Posted (ACTUAL)

February 27, 2020

Study Record Updates

Last Update Posted (ACTUAL)

May 12, 2020

Last Update Submitted That Met QC Criteria

May 11, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Kidney Injury

Clinical Trials on Prone position

3
Subscribe